These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7624111)

  • 1. Pharmacokinetics of 111In-labelled monoclonal antibody ZCE-025 and fragments in tumour-bearing mice.
    Koziol JA; Lee PP; Dillman RO; Fagnani R; Halpern SE
    Nucl Med Commun; 1995 Apr; 16(4):299-305. PubMed ID: 7624111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
    Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
    Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered pharmacokinetic and tumour localization properties of Fab' fragments of a murine monoclonal anti-CEA antibody by covalent modification with low molecular weight dextran.
    Fagnani R; Halpern S; Hagan M
    Nucl Med Commun; 1995 May; 16(5):362-9. PubMed ID: 7544884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
    Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
    J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acetylation on monoclonal antibody ZCE-025 Fab': distribution in normal and tumor-bearing mice.
    Tarburton JP; Halpern SE; Hagan PL; Sudora E; Chen A; Fridman DM; Pfaff AE
    J Biol Response Mod; 1990 Apr; 9(2):221-30. PubMed ID: 2341861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy of human glioma xenografts in nude mice by indium-111 labelled internalising monoclonal antibody.
    Saga T; Sakahara H; Nakamoto Y; Sato N; Zhao S; Aoki T; Miyatake S; Namba Y; Konishi J
    Eur J Cancer; 1999 Aug; 35(8):1281-5. PubMed ID: 10615242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
    Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
    In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts.
    Andrew SM; Perkins AC; Pimm MV; Baldwin RW
    Eur J Nucl Med; 1988; 13(11):598-604. PubMed ID: 3350036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood and tissue kinetics of radiolabelled anti-CEA monoclonal antibody and F(ab)2 and Fab fragments in nude mice with human tumour xenografts: implications for tumour imaging and radioimmunotherapy.
    Pimm MV; Andrew SM; Baldwin RW
    Nucl Med Commun; 1989 Aug; 10(8):585-93. PubMed ID: 2812641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
    Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in an indium-111 Fab' under conditions of utilization.
    Halpern SE; Tarburton JP; Sudora E; Hagan P
    Eur J Nucl Med; 1992; 19(6):387-93. PubMed ID: 1618229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected.
    Westera G; Rülicke T; Smith A; Duewell S
    Cancer Immunol Immunother; 1994 Dec; 39(6):375-82. PubMed ID: 8001025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies.
    Zhu H; Baxter LT; Jain RK
    J Nucl Med; 1997 May; 38(5):731-41. PubMed ID: 9170438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.
    Bares R; Fass J; Truong S; Buell U; Schumpelick V
    Nucl Med Commun; 1989 Sep; 10(9):627-41. PubMed ID: 2616103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
    Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
    Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.